Pounce Thrombectomy System
Commercial- Indications
- Peripheral arterial disease
Company intelligence / Profile preview
Surmodics has a commercial portfolio of medical device products including balloon catheters, thrombectomy platforms, and in vitro diagnostic components. The company’s proprietary coating technologies are widely licensed by major device manufacturers. Its Pounce™ Thrombectomy Platform is FDA-cleared for peripheral arterial clot removal. The company also supplies critical reagents for immunoassays used in clinical diagnostics.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Surmodics.